Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development a... Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements). 詳細を表示
LOS ANGELES, Aug. 08, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.62 | 14.1876430206 | 4.37 | 5.2499 | 4.34 | 56154 | 4.97357227 | CS |
4 | 0.68 | 15.777262181 | 4.31 | 5.47 | 3.95 | 95186 | 4.66323591 | CS |
12 | -0.31 | -5.84905660377 | 5.3 | 6.5 | 3.85 | 80774 | 4.85637088 | CS |
26 | -2.132 | -29.9354114013 | 7.122 | 7.396 | 3.8181 | 146758 | 5.43511216 | CS |
52 | -0.98 | -16.4154103853 | 5.97 | 11 | 3.8181 | 486119 | 7.44990064 | CS |
156 | -73.81 | -93.6675126904 | 78.8 | 102.6 | 3.8181 | 537682 | 29.41717171 | CS |
260 | -192.41 | -97.4721377913 | 197.4 | 356.4 | 3.8181 | 471187 | 53.98717628 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約